Safety Study of the Effect of Scelectium Tortuosum (as Zembrin®)in Aged Normals

Clinical trial NCT01805518 · COMPLETED

Trial details

NCT number: NCT01805518
Sponsor: Woodbury, Michel, M.D.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Adverse Mental/Physical Effects of Low Dose S. Tortuosum.

Start date: 2011-06-01
Primary completion: 2012-03-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.